Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLPT
#2941
ClearPoint Neuro Inc. - Common Stock
15.9
4
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.63%
Monthly Change
+10.62%
6 month change
+61.66%
Year Change
+51.95%
Previous Close
16.3
7
Open
15.9
4
Low
15.9
4
High
15.9
4
Volume
59
Markets
US Stock Market
Healthcare
Medical Devices
CLPT
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
20.67 M
23.69 M
24.61 M
26.98 M
27.63 M
29.66 M
30.5 M
Valuation ratios
Enterprise value
308.39 M
221.53 M
187.03 M
169.17 M
404.88 M
408.96 M
536.54 M
Price to earnings ratio
—
—
-12.24
-7.51
-21.97
-15.2
-14.45
Price to sales ratio
—
—
9.79
6.94
13.24
10.48
11.65
Price to cash flow ratio
—
—
12.44
12.12
46.45
-16.19
-16.28
Price to book ratio
—
—
5.45
7.86
16.37
13.82
6.65
Enterprise value to EBITDA ratio
-512.28
-33.58
-27.86
-15.84
-96.58
-57.78
-57.79
Profitability ratios
Return on assets %
-0.23
-0.22
-0.3
-0.52
-0.48
-0.26
-0.13
Return on equity %
-2.85
-0.3
-0.45
-1.04
-0.74
-0.91
-1.05
Return on invested capital %
-508.54
-709.54
-629.85
-642.05
-594.88
-223.08
-82.1
Gross margin %
71.09
69.27
65.84
56.83
60.92
61.38
61.67
Operating margin %
-48.48
-82.05
-79.47
-93.7
-62.91
-65.36
-94.15
EBITDA margin %
-4.69
-40.48
-32.67
-44.6
-13.35
-19.14
-35.19
Net margin %
-52.86
-88.41
-79.97
-92.21
-60.25
-69.08
-104.2
Liquidity ratios
Quick ratio
6.95
11.98
6.17
3.8
2.56
5.13
3.89
Current ratio
7.96
13.02
7.54
4.87
3.22
5.91
4.74
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.62
0.34
0.34
0.49
0.77
0.38
0.12
Solvency ratios
Debt to assets ratio
—
0.15
0.18
0.23
0
0.5
0.58
Debt to equity ratio
—
0.2
0.27
0.47
0
1.75
4.66
Long term debt to total assets ratio
0.72
0.15
0.18
0.23
0
0.5
0.58
Long term debt to total equity ratio
8.95
0.2
0.27
0.47
0
1.75
4.66
Per share metrics
Operating cash flow per share
—
—
-0.67
-0.56
-0.33
-0.84
-1.04
EBIT per share
—
—
-0.3
-0.46
-0.21
-0.28
-0.34
EBITDA per share
—
—
-0.28
-0.43
-0.16
-0.25
-0.32
Total debt per share
—
—
0.41
0.4
0
1.73
1.67
Cash per share
—
—
1.55
0.94
0.74
1.62
0.97
Net current asset value per share
—
—
2.12
1.47
1.23
2.25
1.62
Tangible book value per share
—
—
1.53
0.86
0.94
0.23
-0.32
Working capital per share
—
—
1.84
1.17
0.85
1.87
1.28
Book value per share
—
—
1.53
0.86
0.94
0.99
0.36
News
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings Call Transcript
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Mettler-Toledo (MTD) Q2 Earnings Surpass Estimates
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?
Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT)
ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case (NASDAQ:CLPT)
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics